IOL CHEMICALS & PHARM. | PLETHICO PHARMA | IOL CHEMICALS & PHARM./ PLETHICO PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | -0.1 | - | View Chart |
P/BV | x | 1.6 | 0.0 | 9,280.9% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. PLETHICO PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
PLETHICO PHARMA Mar-14 |
IOL CHEMICALS & PHARM./ PLETHICO PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 254 | 211.3% | |
Low | Rs | 272 | 31 | 871.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 604.6 | 62.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 32.5 | 72.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 51.3 | 61.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 473.7 | 54.2% | |
Shares outstanding (eoy) | m | 58.71 | 34.07 | 172.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.2 | 454.0% | |
Avg P/E ratio | x | 17.1 | 4.4 | 388.7% | |
P/CF ratio (eoy) | x | 12.8 | 2.8 | 461.3% | |
Price / Book Value ratio | x | 1.6 | 0.3 | 523.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 4,859 | 488.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,547 | 108.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 20,598 | 107.6% | |
Other income | Rs m | 256 | 419 | 61.1% | |
Total revenues | Rs m | 22,427 | 21,017 | 106.7% | |
Gross profit | Rs m | 2,257 | 2,938 | 76.8% | |
Depreciation | Rs m | 462 | 642 | 71.9% | |
Interest | Rs m | 165 | 1,747 | 9.4% | |
Profit before tax | Rs m | 1,887 | 968 | 194.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -138 | -357.8% | |
Profit after tax | Rs m | 1,391 | 1,107 | 125.7% | |
Gross profit margin | % | 10.2 | 14.3 | 71.4% | |
Effective tax rate | % | 26.2 | -14.3 | -183.7% | |
Net profit margin | % | 6.3 | 5.4 | 116.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 18,877 | 51.2% | |
Current liabilities | Rs m | 5,025 | 11,896 | 42.2% | |
Net working cap to sales | % | 20.9 | 33.9 | 61.8% | |
Current ratio | x | 1.9 | 1.6 | 121.2% | |
Inventory Days | Days | 43 | 78 | 55.4% | |
Debtors Days | Days | 8 | 198 | 4.2% | |
Net fixed assets | Rs m | 11,017 | 14,269 | 77.2% | |
Share capital | Rs m | 587 | 341 | 172.3% | |
"Free" reserves | Rs m | 14,490 | 15,798 | 91.7% | |
Net worth | Rs m | 15,077 | 16,139 | 93.4% | |
Long term debt | Rs m | 0 | 4,706 | 0.0% | |
Total assets | Rs m | 20,684 | 33,146 | 62.4% | |
Interest coverage | x | 12.5 | 1.6 | 801.2% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.6 | 172.5% | |
Return on assets | % | 7.5 | 8.6 | 87.4% | |
Return on equity | % | 9.2 | 6.9 | 134.6% | |
Return on capital | % | 13.6 | 13.0 | 104.4% | |
Exports to sales | % | 26.7 | 21.4 | 125.1% | |
Imports to sales | % | 0 | 15.2 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 4,402 | 134.7% | |
Imports (cif) | Rs m | NA | 3,136 | 0.0% | |
Fx inflow | Rs m | 5,930 | 4,402 | 134.7% | |
Fx outflow | Rs m | 6,052 | 3,184 | 190.1% | |
Net fx | Rs m | -122 | 1,219 | -10.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 2,437 | 50.2% | |
From Investments | Rs m | -1,200 | -6,265 | 19.2% | |
From Financial Activity | Rs m | -41 | 2,490 | -1.7% | |
Net Cashflow | Rs m | -18 | 24 | -75.2% |
Indian Promoters | % | 48.2 | 57.8 | 83.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 19.4 | 8.8% | |
FIIs | % | 1.4 | 2.7 | 51.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 42.3 | 122.6% | |
Shareholders | 130,003 | 16,430 | 791.3% | ||
Pledged promoter(s) holding | % | 0.0 | 85.7 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | PLETHICO PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | -4.91% | 0.45% |
1-Month | 5.76% | -1.24% | 2.55% |
1-Year | -2.63% | -70.21% | 56.14% |
3-Year CAGR | -12.88% | -66.86% | 15.22% |
5-Year CAGR | 16.82% | -51.20% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the PLETHICO PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of PLETHICO PHARMA the stake stands at 57.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of PLETHICO PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
PLETHICO PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of PLETHICO PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.